Cargando…

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes

Paraoxonase-1 (PON1) and lipoprotein phospholipase A2 (Lp-PLA2) may exert an important protective role by preventing the oxidative transformation of high- and low-density lipoproteins (HDL and LDL, respectively). The activity of both enzymes is influenced by lipidome and proteome of the lipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Passaro, Angelina, Vigna, Giovanni Battista, Romani, Arianna, Sanz, Juana M., Cavicchio, Carlotta, Bonaccorsi, Gloria, Valacchi, Giuseppe, Cervellati, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247389/
https://www.ncbi.nlm.nih.gov/pubmed/30524650
http://dx.doi.org/10.1155/2018/1752940
_version_ 1783372463867953152
author Passaro, Angelina
Vigna, Giovanni Battista
Romani, Arianna
Sanz, Juana M.
Cavicchio, Carlotta
Bonaccorsi, Gloria
Valacchi, Giuseppe
Cervellati, Carlo
author_facet Passaro, Angelina
Vigna, Giovanni Battista
Romani, Arianna
Sanz, Juana M.
Cavicchio, Carlotta
Bonaccorsi, Gloria
Valacchi, Giuseppe
Cervellati, Carlo
author_sort Passaro, Angelina
collection PubMed
description Paraoxonase-1 (PON1) and lipoprotein phospholipase A2 (Lp-PLA2) may exert an important protective role by preventing the oxidative transformation of high- and low-density lipoproteins (HDL and LDL, respectively). The activity of both enzymes is influenced by lipidome and proteome of the lipoprotein carriers. T2DM typically presents significant changes in the molecular composition of the lipoprotein subclasses. Thus, it becomes relevant to understand the interaction of PON1 and Lp-PLA2 with the subspecies of HDL, LDL, and other lipoproteins in T2DM. Serum levels of PON1-arylesterase and PON1-lactonase and Lp-PLA2 activities and lipoprotein subclasses were measured in 202 nondiabetic subjects (controls) and 92 T2DM outpatients. Arylesterase, but not lactonase or Lp-PLA2 activities, was inversely associated with TD2M after adjusting for potential confounding factors such as age, sex, smoking, body mass index, hypertension, and lipoprotein subclasses (odds ratio = 3.389, 95% confidence interval 1.069–14.756). Marked difference between controls and T2DM subjects emerged from the analyses of the associations of the three enzyme activities and lipoprotein subclasses. Arylesterase was independently related with large HDL-C and small intermediate-density lipoprotein cholesterol (IDL-C) in controls while, along with lactonase, it was related with small low-density lipoprotein cholesterol LDL-C, all IDL-C subspecies, and very low-density lipoprotein cholesterol (VLDL-C) in T2DM (p < 0.05 for all). Concerning Lp-PLA2, there were significant relationships with small LDL-C, large IDL-C, and VLDL-C only among T2DM subjects. Our study showed that T2DM subjects have lower levels of PON1-arylesterase compared to controls and that T2DM occurrence may coincide with a shift of PON1 and Lp-PLA2 towards the more proatherogenic lipoprotein subclasses. The possibility of a link between the two observed phenomena requires further investigations.
format Online
Article
Text
id pubmed-6247389
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62473892018-12-06 Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes Passaro, Angelina Vigna, Giovanni Battista Romani, Arianna Sanz, Juana M. Cavicchio, Carlotta Bonaccorsi, Gloria Valacchi, Giuseppe Cervellati, Carlo Oxid Med Cell Longev Research Article Paraoxonase-1 (PON1) and lipoprotein phospholipase A2 (Lp-PLA2) may exert an important protective role by preventing the oxidative transformation of high- and low-density lipoproteins (HDL and LDL, respectively). The activity of both enzymes is influenced by lipidome and proteome of the lipoprotein carriers. T2DM typically presents significant changes in the molecular composition of the lipoprotein subclasses. Thus, it becomes relevant to understand the interaction of PON1 and Lp-PLA2 with the subspecies of HDL, LDL, and other lipoproteins in T2DM. Serum levels of PON1-arylesterase and PON1-lactonase and Lp-PLA2 activities and lipoprotein subclasses were measured in 202 nondiabetic subjects (controls) and 92 T2DM outpatients. Arylesterase, but not lactonase or Lp-PLA2 activities, was inversely associated with TD2M after adjusting for potential confounding factors such as age, sex, smoking, body mass index, hypertension, and lipoprotein subclasses (odds ratio = 3.389, 95% confidence interval 1.069–14.756). Marked difference between controls and T2DM subjects emerged from the analyses of the associations of the three enzyme activities and lipoprotein subclasses. Arylesterase was independently related with large HDL-C and small intermediate-density lipoprotein cholesterol (IDL-C) in controls while, along with lactonase, it was related with small low-density lipoprotein cholesterol LDL-C, all IDL-C subspecies, and very low-density lipoprotein cholesterol (VLDL-C) in T2DM (p < 0.05 for all). Concerning Lp-PLA2, there were significant relationships with small LDL-C, large IDL-C, and VLDL-C only among T2DM subjects. Our study showed that T2DM subjects have lower levels of PON1-arylesterase compared to controls and that T2DM occurrence may coincide with a shift of PON1 and Lp-PLA2 towards the more proatherogenic lipoprotein subclasses. The possibility of a link between the two observed phenomena requires further investigations. Hindawi 2018-11-05 /pmc/articles/PMC6247389/ /pubmed/30524650 http://dx.doi.org/10.1155/2018/1752940 Text en Copyright © 2018 Angelina Passaro et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Passaro, Angelina
Vigna, Giovanni Battista
Romani, Arianna
Sanz, Juana M.
Cavicchio, Carlotta
Bonaccorsi, Gloria
Valacchi, Giuseppe
Cervellati, Carlo
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title_full Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title_fullStr Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title_full_unstemmed Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title_short Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
title_sort distribution of paraoxonase-1 (pon-1) and lipoprotein phospholipase a2 (lp-pla2) across lipoprotein subclasses in subjects with type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247389/
https://www.ncbi.nlm.nih.gov/pubmed/30524650
http://dx.doi.org/10.1155/2018/1752940
work_keys_str_mv AT passaroangelina distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT vignagiovannibattista distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT romaniarianna distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT sanzjuanam distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT cavicchiocarlotta distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT bonaccorsigloria distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT valacchigiuseppe distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes
AT cervellaticarlo distributionofparaoxonase1pon1andlipoproteinphospholipasea2lppla2acrosslipoproteinsubclassesinsubjectswithtype2diabetes